Skip to main content
. Author manuscript; available in PMC: 2016 Jun 30.
Published in final edited form as: J Nat Prod. 2004 Aug;67(8):1314–1318. doi: 10.1021/np0400095

Table 3.

HIV-1 and AIDS Opportunistic Infections Data for Manzaminesa

compound activity IC50 (μg/mL)
S. aureus MRS C. neoformans M. intracellulare HIV-1 EC50 (μM)
manzamine A (2) 0.5 0.7 3.0 0.35 4.2
8-hydroxymanzamine A (6) 0.9 4.0 3.0 1.0 0.59
manzamine A N-oxide (5) 0.5 0.4 1.0 0.2 NT
3,4-dihydromanzamine A N-oxide NA NA NA NA NA
12,34-oxamanzamine E (3) NA NA NA NA NT
manzamine E (7) NA NA NA 12.5 13.1
6-hydroxymanzamine E (8) NT NT 5.5 3.5 NT
manzamine F (9) NA NA 6.5 6.25 7.3
manzamine J (1) NA NA NA 15 NT
8-hydroxymanzamine J (4) 3.0 5.0 3.5 0.45 NT
6-deoxymanzamine X 1.5 1.5 2.0 6.25 1.6
manzamime X 1.0 0.75 3.0 1.5 2.3
neo-kauluamine NA NA 3.0 3.0 2.3
ircinal A NA NA NA 50 6.8
ircinol A (10) NA 30 NA 50 4.3
amphotericin B NT NT 0.15 NT NT
ciprofloxacin 0.10 0.10 NT 0.25 NT
a

NA = not active. NT = not tested.